Companies › Merz Therapeutics
1 active drug program in 10 registered trials: 4 Phase 3, 4 Phase 2, 2 Phase 4; Neurology, Genitourinary, Immunology, Other; next expected readout Mar 2027.
Open in Phaseline: competitors, likelihood bands and readouts Company report
| Drug | Target | Highest phase | Conditions | Next expected readout |
|---|---|---|---|---|
| Incobotulinumtoxina Synaptosomal nerve-associated protein 25 (SNAP-25) inhibitor | SNAP25 | Phase 3 | Chronic Migraine; Episodic Migraine; Fissure in Ano; Stroke … | Mar 2027 |
| Registry id | Drug | Phase | Conditions | Area | Expected readout |
|---|---|---|---|---|---|
| NCT03855046 | Incobotulinumtoxina | Phase 4 | Fissure in Ano | Genitourinary | Sep 2022 |
| NCT03571334 | Incobotulinumtoxina | Phase 2 | Peripheral Neuropathy Due to Chemotherapy | Neurology | Dec 2023 |
| NCT05456087 | Incobotulinumtoxina | Phase 2 | Androgenetic Alopecia | Immunology | Dec 2024 |
| NCT07486830 | Incobotulinumtoxina | Phase 2 | Provoked Vestibulodynia | Genitourinary | Dec 2026 |
| NCT05327972 | Incobotulinumtoxina | Phase 2 | Degenerative Rotator Cuff Disease | Other | Feb 2027 |
| NCT05598723 | Incobotulinumtoxina | Phase 3 | Chronic Migraine | Neurology | Feb 2027 |
| NCT07018713 | Incobotulinumtoxina | Phase 3 | Chronic Migraine | Neurology | Mar 2027 |
| NCT07018700 | Incobotulinumtoxina | Phase 3 | Episodic Migraine | Neurology | Mar 2027 |
| NCT03977493 | Incobotulinumtoxina | Phase 3 | Focal Hand Dystonia | Neurology | Dec 2027 |
| NCT04908423 | Incobotulinumtoxina | Phase 4 | Stroke | Neurology | Apr 2028 |
AbbVie Biojiva Ipsen Huons Biopharma Merz Aesthetics Merz Pharmaceuticals Merz North America
Merz Pharmaceuticals Merz Aesthetics Merz North America Hansa Biopharma Chongqing Claruvis Pharmaceutical
Pipelines of the same shape: areas, drug types, target families, stage and cash runway.
Programs group the company's trials by drug; the target and mechanism come from Open Targets and ChEMBL via Open Targets; expected readouts are Phaseline's estimate from the registry's primary completion date. Facts from the registries only; the approval likelihood, shown as a band with its track record, is in the app.